4//SEC Filing
Williams Laura A 4
Accession 0001628280-25-007234
CIK 0001437402other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:56 PM ET
Size
5.5 KB
Accession
0001628280-25-007234
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Williams Laura A
Chief Patient Officer
Transactions
- Sale
Common Stock
2025-02-20$5.62/sh−4,941$27,783→ 303,804 total
Footnotes (2)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Transaction was executed in multiple trades in prices ranging from $5.601611 to $5.625428, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
ARDELYX, INC.
CIK 0001437402
Entity typeother
Related Parties
1- filerCIK 0001869194
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:56 PM ET
- Size
- 5.5 KB